Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Transmedics Group Inc (TMDX)

Transmedics Group Inc (TMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Transmedics Group Inc 200 MINUTEMAN ROAD ANDOVER MA 01810 USA

www.transmedics.com Employees: 728 P: 978-552-0900

Sector:

Medical

Description:

TransMedics Inc. is a commercial-stage medical technology company. It is engaged in transforming organ transplant therapy for end-stage organ failure patients. The company offers Organ Care System, an integrated, compact, portable preservation technology which addresses unmet need for organs for transplantation. TransMedics Inc. is headquartered in Andover, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 4,982,707
Enterprise Value, $K 4,705,427
Shares Outstanding, K 34,302
Float, K 31,901
% Float 93.00%
Short Interest, K 7,891
Short Float 23.09%
Days to Cover 9.23
Short Volume Ratio 0.55
% of Insider Shareholders 7.00%
% of Institutional Shareholders 99.67%

Financials:

Annual Sales, $ 441,540 K
Annual Net Income, $ 35,460 K
Last Quarter Sales, $ 143,820 K
Last Quarter Net Income, $ 24,320 K
EBIT, $ 95,950 K
EBITDA, $ 115,710 K

Growth:

1-Year Return 101.41%
3-Year Return 76.44%
5-Year Return 357.08%
5-Year Revenue Growth 1,770.93%
5-Year Earnings Growth 142.80%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 2.62 on 02/24/26
Next Earnings Date 05/14/26
Earnings Per Share ttm 2.47
EPS Growth vs. Prev Qtr -13.64%
EPS Growth vs. Prev Year 200.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TMDX Ratios

Ratio
Price/Earnings ttm 50.97
Price/Earnings forward 48.63
Price/Earnings to Growth N/A
Return-on-Equity % 30.17%
Return-on-Assets % 11.39%
Profit Margin % 8.03%
Debt/Equity 0.17
Price/Sales 8.23
Price/Cash Flow 34.27
Price/Book 9.76
Book Value/Share 10.40
Interest Coverage 3.48
60-Month Beta 2.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar